← Leaderboards
Matthew D Disney
State University Of New York At Buffalo
$28,195,698
Attributed
$29,530,396
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,065,484 · 13
By mechanism
R01$11,346,080 · 3
P01$8,937,104 · 3
R35$8,043,375 · 1
DP1$4,972,013 · 1
UH3$851,067 · 1
R33$843,131 · 1
Top collaborators
- Leonard Petrucelli6 shared
- Jeffrey D Rothstein6 shared
- M. Maral Mouradian5 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Marilyn Emily Morris$3,163,244
- Sandra L McFadden$1,731,678
- Eri Hashino$1,569,058
- Kathleen M Tornatore$3,934,914
- Sathy Venkat Balu-Iyer$6,910,696
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeDesignLeadStructureIn VivoCellsProteinsPharmaceutical PreparationsIn VitroBindingBiologyBaseInnovationDementiaProgramsPropertyDefectRna BindingStructure-Activity RelationshipTranscriptAffectMicrornasTherapeutic TargetGenes
Grant awards (58)
Design of Precision Small Molecules Targeting RNA Repeating Transcripts to Manipulate and Study Disease Biology$1,387,500
R35 · FY2025 · NS · contact PI
Targeted degradation of RNAs by using small molecules$759,311
R01 · FY2025 · CA · contact PI
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology$1,345,875
R35 · FY2024 · NS · contact PI
Targeted degradation of RNAs by using small molecules$641,325
R01 · FY2024 · CA · contact PI
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology$1,387,500
R35 · FY2023 · NS · contact PI
Targeted degradation of RNAs by using small molecules$661,575
R01 · FY2023 · CA · contact PI
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology$1,387,500
R35 · FY2022 · NS · contact PI
Targeted degradation of RNAs by using small molecules$661,575
R01 · FY2022 · CA · contact PI
RNA Targeted Drug Discovery and Development for Parkinson Disease$851,067
UH3 · FY2021 · NS
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology$725,374
R35 · FY2021 · NS · contact PI
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways$677,625
P01 · FY2021 · NS · contact PI
Targeted degradation of RNAs by using small molecules$675,077
R01 · FY2021 · CA · contact PI
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology$662,126
R35 · FY2021 · NS · contact PI
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways$413,819
P01 · FY2021 · NS · contact PI
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms$259,425
P01 · FY2021 · NS · contact PI
Administrative Core$133,018
P01 · FY2021 · NS · contact PI
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology$1,147,500
R35 · FY2020 · NS · contact PI
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways$1,091,444
P01 · FY2020 · NS · contact PI
Targeted degradation of RNAs by using small molecules$696,325
R01 · FY2020 · CA · contact PI
RNA Targeted Drug Discovery and Development for Parkinson Disease$522,761
UG3 · FY2020 · NS
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms$259,425
P01 · FY2020 · NS · contact PI
Administrative Core$133,018
P01 · FY2020 · NS · contact PI
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways$1,435,400
P01 · FY2019 · NS · contact PI
Using a disease-affected cell to synthesize its own drug$960,000
DP1 · FY2019 · NS · contact PI
Sequence-based Design of Small Molecules Targeting RNA$623,961
R01 · FY2019 · GM · contact PI
Developing Novel RNA-Based Therapeutics for Parkinson's Disease$424,450
R33 · FY2019 · NS
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms$348,955
P01 · FY2019 · NS · contact PI
Administrative Core$163,330
P01 · FY2019 · NS · contact PI
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways$1,435,400
P01 · FY2018 · NS · contact PI
Using a disease-affected cell to synthesize its own drug$987,030
DP1 · FY2018 · NS · contact PI
Sequence-based Design of Small Molecules Targeting RNA$623,961
R01 · FY2018 · GM · contact PI
Developing Novel RNA-Based Therapeutics for Parkinson's Disease$418,681
R33 · FY2018 · NS
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms$348,955
P01 · FY2018 · NS · contact PI
Administrative Core$163,330
P01 · FY2018 · NS · contact PI
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways$1,481,400
P01 · FY2017 · NS · contact PI
Using a disease-affected cell to synthesize its own drug$1,051,569
DP1 · FY2017 · NS · contact PI
Sequence-based Design of Small Molecules Targeting RNA$623,961
R01 · FY2017 · GM · contact PI
Developing Novel RNA-Based Therapeutics for Parkinson's Disease$452,438
R21 · FY2017 · NS
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms$296,280
P01 · FY2017 · NS · contact PI
Administrative Core$296,280
P01 · FY2017 · NS · contact PI
Using a disease-affected cell to synthesize its own drug$53,414
DP1 · FY2017 · NS · contact PI
Using a disease-affected cell to synthesize its own drug$960,000
DP1 · FY2016 · NS · contact PI
Sequence-based Design of Small Molecules Targeting RNA$646,961
R01 · FY2016 · GM · contact PI
Using a disease-affected cell to synthesize its own drug$960,000
DP1 · FY2015 · NS · contact PI
Developing Reliable In Silico Methods to Design Small Molecules Targeting RNA$735,300
R01 · FY2015 · GM · contact PI
Developing Reliable In Silico Methods to Design Small Molecules Targeting RNA$376,200
R01 · FY2014 · GM · contact PI
Developing Reliable In Silico Methods to Design Small Molecules Targeting RNA$269,325
R01 · FY2014 · GM · contact PI
Developing Reliable In Silico Methods to Design Small Molecules Targeting RNA$363,033
R01 · FY2013 · GM · contact PI
HTS to Identify Small Molecules Targeting Repeating Transcripts$48,015
R03 · FY2013 · DA · contact PI
Developing Reliable In Silico Methods to Design Small Molecules Targeting RNA$376,200
R01 · FY2012 · GM · contact PI
Identifying and Studying RNA Loop-Small Molecule Interactions$368,714
R01 · FY2012 · GM · contact PI
HTS to Identify Small Molecules Targeting Repeating Transcripts$49,500
R03 · FY2012 · DA · contact PI
Identifying and Studying RNA Loop-Small Molecule Interactions$368,714
R01 · FY2011 · GM · contact PI
Identifying and Studying RNA Loop-Small Molecule Interactions$365,855
R01 · FY2010 · GM · contact PI
Identifying and Studying RNA Loop-Small Molecule Interactions$772,062
R01 · FY2009 · GM · contact PI
Identifying and Studying RNA Loop-Small Molecule Interactions$295,132
R01 · FY2009 · GM · contact PI
Identifying and Studying RNA Loop-Small Molecule Interactions$143,372
R01 · FY2009 · GM · contact PI
Identifying and Studying RNA Loop-Small Molecule Interactions$298,141
R01 · FY2008 · GM · contact PI